|
...responsabile del progetto di ricerca Istituto di analisi dei sistemi ed informatica "Antonio Ruberti" (IASI) PRIN 2017 - PRIN2017S55RXB - Antonella Farsetti - New Biomarkers for Pituitary Tumor (DIT. ...
CNR
-
12-6-2025
|
|
|
|
It assists physicians in performing percutaneous tumor ablations, where one or more needles are inserted through the skin to destroy the tumor. This minimally invasive treatment provides patients ...
01Net
-
10-6-2025
|
|
|
|
Its resources support a broad range of applications from AI/ML modeling and multi - omics research to drug screening in patient tumor - derived cells and biomarker discovery. Sapien has published ...
01Net
-
4-6-2025
|
|
|
|
... ossia su come trasformare il fenotipo delle cellule tumorali da maligno a benigno, processo definito a livello accademico tumor reversion , credendo che i processi di sviluppo embrionale che ...
AgenPress
-
3-6-2025
|
|
|
|
... Aspera aims to investigate an expanded group of tumor indications for rebecsinib in patient derived tumor organoids to prevent the leading causes of cancer mortalitytherapeutic resistance - related ...
01Net
-
3-6-2025
|
|
|
|
Grande partecipazione alla tappa di Cesano Maderno del Giro d'Italia, dove Merck ha portato la campagna 'Non girarci intorno' per sensibilizzare sul tumore uroteliale. Durante l'evento, svoltosi ...
Sardegna News
-
31-5-2025
|
|
|
|
This unique approach ensures robust, reproducible results across different patient populations and tumor types. "OncoPrism is bridging the precision medicine gap by providing clinicians with reliable ...
01Net
-
30-5-2025
|
|
|
|
WARNINGS AND PRECAUTIONS Risk of Misdiagnosis Inadequate Tumor Characterization and Other ER - Positive Pathology Breast cancer may be heterogeneous within patients and across time. CERIANNA images ...
01Net
-
30-5-2025
|
|
|
|
Poster Presentation (213/3544): Circulating tumor DNA (ctDNA) dynamics in liver - limited metastatic colorectal cancer (mCRC) patients resected after first - line systemic treatment Date/Time: ...
01Net
-
30-5-2025
|
|
|
|
... Serial CTRS, which evaluates changes across routine CT scans over time to predict overall survival in late - stage non"small cell lung cancer (NSCLC) and other solid tumor types. In collaboration ...
01Net
-
30-5-2025
|
|
|
